{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 0, \"reasoning\": \"The criterion specifically asks whether the response suggests that a small number of executives (e.g., 2-5 FTEs) are sufficient substance for a major pharma group's global IP principal. The candidate answer recommends IrishCo have 'substance' including 'Employees (e.g., sales, marketing, finance) making real decisions' and 'Board meetings held in Ireland with local directors.' While it mentions employees, it does not explicitly state or imply that a small number (2-5 FTEs) is sufficient for a major pharma group's global IP principal, which is the specific trigger for this criterion. The answer focuses on the structure (CSA/PSM) and general substance requirements, not quantifying the minimum FTE count required for the IP principal role.\", \"criterion_id\": \"77a6a9a4-85a5-4ef3-a58c-6a3623970e43\"}", "usage": {"prompt_tokens": 2548, "completion_tokens": 208, "total_tokens": 2756}, "latency_s": 1.2932063749758527, "request_id": "Tf2UaenzF6L17M8Pt6zc8AU", "raw_response": null}